These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
497 related items for PubMed ID: 8438295
1. Importance of HLA matching in highly sensitised renal transplant recipients with high transplant survival rates. The Manchester Kidney Transplant Team. Martin S, Connolly J, Jos V. Transplant Proc; 1993 Feb; 25(1 Pt 1):265-6. PubMed ID: 8438295 [No Abstract] [Full Text] [Related]
10. HLA-DR matching is effective in reducing posttransplant costs in renal allograft recipients on triple therapy. Taylor CJ, Bayne AM, Welsh KI, Morris PJ. Transplant Proc; 1993 Feb; 25(1 Pt 1):210-1. PubMed ID: 8438273 [No Abstract] [Full Text] [Related]
11. Beneficial effect of DR matching on cadaveric renal graft survival in Scandiatransplant. Leivestad T, Berger L, Thorsby E. Transplant Proc; 1992 Dec; 24(6):2447-8. PubMed ID: 1465824 [No Abstract] [Full Text] [Related]
12. Dissection of the respective importance of HLA-A,B,DR matching in 3,789 prospective kidney transplants. Hors J, Busson M, Bouteiller AM, Raffoux C, Betuel H, Fauchet R, Tongio MM, Mercier P, Lepetit JC, Dausset J. Transplant Proc; 1987 Feb; 19(1 Pt 1):687-8. PubMed ID: 3274842 [No Abstract] [Full Text] [Related]
13. Renal after cardiothoracic transplant: the effect of repeat mismatches on outcome. Caskey FJ, Johnson RJ, Fuggle SV, Start S, Pugh D, Dudley CR. Transplantation; 2009 Jun 15; 87(11):1727-32. PubMed ID: 19502967 [Abstract] [Full Text] [Related]
14. Association between long-term kidney graft survival and the presence of pre-transplant cytotoxic anti-HLA and/or non-MHC 'Fc gamma RII blocking' (anti-TLX) alloantibody. Padányi A, Gyódi E, Rajczy K, Perner F, Petrányi GG. Clin Transplant; 1996 Oct 15; 10(5):455-60. PubMed ID: 8930462 [Abstract] [Full Text] [Related]
15. Repeated mismatches may not impair survival of renal regrafts in recipients with 0% to 50% panel reactive antibodies. Mjörnstedt L, Konar J, Skarp I, Olausson M, Sandberg L, Tufvesson G. Transplant Proc; 1992 Dec 15; 24(6):2469. PubMed ID: 1465834 [No Abstract] [Full Text] [Related]